Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Scott Schoenhaus is an analyst at Keybanc. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/12/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/11/2024 | ABCL | Buy Now | AbCellera Biologics | $3.25 | 53.89% | $7 → $5 | Maintains | Overweight | Get Alert |
| 07/11/2024 | ABSI | Buy Now | Absci | $4.00 | 50% | $8 → $6 | Maintains | Overweight | Get Alert |
| 07/11/2024 | ALIT | Buy Now | Alight | $7.35 | 36.05% | $11 → $10 | Maintains | Overweight | Get Alert |
| 07/11/2024 | CERT | Buy Now | Certara | $15.67 | 27.63% | $23 → $20 | Maintains | Overweight | Get Alert |
| 07/11/2024 | LFMD | Buy Now | LifeMD | $6.69 | 49.48% | $12 → $10 | Maintains | Overweight | Get Alert |
| 07/11/2024 | PHR | Buy Now | Phreesia | $22.82 | 9.55% | $27 → $25 | Maintains | Overweight | Get Alert |
| 07/11/2024 | RXRX | Buy Now | Recursion Pharmaceuticals | $8.23 | 45.81% | $16 → $12 | Maintains | Overweight | Get Alert |
| 07/11/2024 | SDGR | Buy Now | Schrodinger | $22.50 | 11.11% | $30 → $25 | Maintains | Overweight | Get Alert |
| 06/05/2024 | HQY | Buy Now | HealthEquity | $77.06 | 29.77% | $95 → $100 | Maintains | Overweight | Get Alert |
| 06/05/2024 | LFMD | Buy Now | LifeMD | $6.69 | 79.37% | → $12 | Initiates | → Overweight | Get Alert |
| 05/10/2024 | PGNY | Buy Now | Progyny | $29.03 | — | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 05/09/2024 | ALIT | Buy Now | Alight | $7.35 | 49.66% | $12 → $11 | Maintains | Overweight | Get Alert |
| 05/08/2024 | ABCL | Buy Now | AbCellera Biologics | $3.25 | 115.45% | $8 → $7 | Maintains | Overweight | Get Alert |
| 04/10/2024 | RCM | Buy Now | R1 RCM | $12.79 | — | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 04/10/2024 | HCAT | Buy Now | Health Catalyst | $6.51 | — | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 04/10/2024 | GDRX | Buy Now | GoodRx Holdings | $8.27 | 8.83% | → $9 | Upgrade | Sector Weight → Overweight | Get Alert |
| 04/10/2024 | CERT | Buy Now | Certara | $15.67 | 46.78% | → $23 | Upgrade | Sector Weight → Overweight | Get Alert |
| 03/22/2024 | HQY | Buy Now | HealthEquity | $77.06 | 23.28% | $85 → $95 | Maintains | Overweight | Get Alert |
| 03/05/2024 | VEEV | Buy Now | Veeva Sys | $185.74 | 34.6% | $232 → $250 | Maintains | Overweight | Get Alert |
| 03/04/2024 | RXRX | Buy Now | Recursion Pharmaceuticals | $8.23 | 94.41% | $15 → $16 | Maintains | Overweight | Get Alert |
| 03/04/2024 | ABSI | Buy Now | Absci | $4.00 | 100% | $5 → $8 | Maintains | Overweight | Get Alert |
| 02/29/2024 | SDGR | Buy Now | Schrodinger | $22.50 | 46.67% | $38 → $33 | Maintains | Overweight | Get Alert |
| 02/29/2024 | RCM | Buy Now | R1 RCM | $12.79 | 32.92% | $13 → $17 | Maintains | Overweight | Get Alert |
| 02/26/2024 | HCAT | Buy Now | Health Catalyst | $6.51 | 53.61% | $12 → $10 | Maintains | Overweight | Get Alert |
| 01/24/2024 | VEEV | Buy Now | Veeva Sys | $185.74 | 24.91% | $210 → $232 | Maintains | Overweight | Get Alert |
| 01/05/2024 | RCM | Buy Now | R1 RCM | $12.79 | 1.64% | $18 → $13 | Maintains | Overweight | Get Alert |
| 01/05/2024 | ABSI | Buy Now | Absci | $4.00 | 25% | $3 → $5 | Maintains | Overweight | Get Alert |
| 12/08/2023 | VEEV | Buy Now | Veeva Sys | $185.74 | 13.06% | $230 → $210 | Maintains | Overweight | Get Alert |
| 12/07/2023 | PHR | Buy Now | Phreesia | $22.82 | 31.46% | $40 → $30 | Maintains | Overweight | Get Alert |
| 12/05/2023 | CERT | Buy Now | Certara | $15.67 | — | — | Initiates | → Sector Weight | Get Alert |
| 12/05/2023 | SDGR | Buy Now | Schrodinger | $22.50 | 68.89% | → $38 | Initiates | → Overweight | Get Alert |
| 12/05/2023 | ABSI | Buy Now | Absci | $4.00 | -25% | → $3 | Initiates | → Overweight | Get Alert |
| 12/05/2023 | ABCL | Buy Now | AbCellera Biologics | $3.25 | 84.67% | → $6 | Initiates | → Overweight | Get Alert |
| 11/08/2023 | PGNY | Buy Now | Progyny | $29.03 | 55.01% | $50 → $45 | Maintains | Overweight | Get Alert |
| 11/03/2023 | RCM | Buy Now | R1 RCM | $12.79 | 40.73% | $20 → $18 | Maintains | Overweight | Get Alert |
| 10/11/2023 | VEEV | Buy Now | Veeva Sys | $185.74 | 23.83% | $220 → $230 | Maintains | Overweight | Get Alert |
| 10/11/2023 | OMCL | Buy Now | Omnicell | $26.44 | — | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 08/15/2023 | ODD | Buy Now | ODDITY Tech | $43.08 | 39.28% | — | Initiates | → Overweight | Get Alert |
| 08/04/2023 | PGNY | Buy Now | Progyny | $29.03 | 72.24% | $45 → $50 | Maintains | Overweight | Get Alert |
| 08/04/2023 | OMCL | Buy Now | Omnicell | $26.44 | 183.66% | $80 → $75 | Maintains | Overweight | Get Alert |
| 08/03/2023 | ALIT | Buy Now | Alight | $7.35 | 63.27% | $15 → $12 | Maintains | Overweight | Get Alert |
| 07/13/2023 | RXRX | Buy Now | Recursion Pharmaceuticals | $8.23 | 82.26% | $12 → $15 | Maintains | Overweight | Get Alert |
| 07/13/2023 | OMCL | Buy Now | Omnicell | $26.44 | 202.57% | $70 → $80 | Maintains | Overweight | Get Alert |
| 07/12/2023 | GDRX | Buy Now | GoodRx Holdings | $8.27 | — | — | Maintains | Sector Weight | Get Alert |
| 06/02/2023 | VEEV | Buy Now | Veeva Sys | $185.74 | 13.06% | $185 → $210 | Maintains | Overweight | Get Alert |
| 05/25/2023 | VEEV | Buy Now | Veeva Sys | $185.74 | -0.4% | $200 → $185 | Maintains | Overweight | Get Alert |
| 05/25/2023 | PHR | Buy Now | Phreesia | $22.82 | 75.28% | $45 → $40 | Maintains | Overweight | Get Alert |
| 05/09/2023 | RXRX | Buy Now | Recursion Pharmaceuticals | $8.23 | 45.81% | $20 → $12 | Maintains | Overweight | Get Alert |
| 05/03/2023 | OMCL | Buy Now | Omnicell | $26.44 | 164.75% | $65 → $70 | Maintains | Overweight | Get Alert |
| 04/20/2023 | HCAT | Buy Now | Health Catalyst | $6.51 | 145.78% | → $16 | Upgrade | Sector Weight → Overweight | Get Alert |
| 03/03/2023 | VEEV | Buy Now | Veeva Sys | $185.74 | 7.68% | $210 → $200 | Maintains | Overweight | Get Alert |
| 03/02/2023 | OMCL | Buy Now | Omnicell | $26.44 | 145.84% | $70 → $65 | Maintains | Overweight | Get Alert |
| 02/02/2023 | RCM | Buy Now | R1 RCM | $12.79 | 56.37% | $15 → $20 | Maintains | Overweight | Get Alert |
| 02/02/2023 | PHR | Buy Now | Phreesia | $22.82 | 97.2% | $40 → $45 | Maintains | Overweight | Get Alert |
| 02/02/2023 | OMCL | Buy Now | Omnicell | $26.44 | 164.75% | $75 → $70 | Maintains | Overweight | Get Alert |
| 12/19/2022 | PGNY | Buy Now | Progyny | $29.03 | 55.01% | $55 → $45 | Maintains | Overweight | Get Alert |
| 12/05/2022 | VEEV | Buy Now | Veeva Sys | $185.74 | 13.06% | $220 → $210 | Maintains | Overweight | Get Alert |
| 12/05/2022 | RCM | Buy Now | R1 RCM | $12.79 | 17.28% | $10 → $15 | Maintains | Overweight | Get Alert |
| 11/09/2022 | RCM | Buy Now | R1 RCM | $12.79 | -21.81% | $30 → $10 | Maintains | Overweight | Get Alert |
| 11/08/2022 | BNFT | Buy Now | Benefitfocus | — | — | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 11/03/2022 | OMCL | Buy Now | Omnicell | $26.44 | 183.66% | $130 → $75 | Maintains | Overweight | Get Alert |
| 09/16/2022 | ALIT | Buy Now | Alight | $7.35 | 104.08% | → $15 | Initiates | → Overweight | Get Alert |
| 09/16/2022 | MDRX | Buy Now | Veradigm | $9.85 | — | — | Initiates | → Sector Weight | Get Alert |
| 09/16/2022 | BNFT | Buy Now | Benefitfocus | — | — | → $10 | Initiates | → Overweight | Get Alert |
| 09/16/2022 | GDRX | Buy Now | GoodRx Holdings | $8.27 | — | — | Initiates | → Sector Weight | Get Alert |
| 09/16/2022 | HCAT | Buy Now | Health Catalyst | $6.51 | — | — | Initiates | → Sector Weight | Get Alert |
| 09/16/2022 | HQY | Buy Now | HealthEquity | $77.06 | 10.3% | → $85 | Initiates | → Overweight | Get Alert |
| 09/16/2022 | OMCL | Buy Now | Omnicell | $26.44 | 391.68% | → $130 | Initiates | → Overweight | Get Alert |
| 09/16/2022 | PHR | Buy Now | Phreesia | $22.82 | 75.28% | → $40 | Initiates | → Overweight | Get Alert |
| 09/16/2022 | RXRX | Buy Now | Recursion Pharmaceuticals | $8.23 | 143.01% | → $20 | Initiates | → Overweight | Get Alert |
| 09/16/2022 | RCM | Buy Now | R1 RCM | $12.79 | 134.56% | → $30 | Initiates | → Overweight | Get Alert |
| 09/16/2022 | PGNY | Buy Now | Progyny | $29.03 | 89.46% | → $55 | Maintains | Overweight | Get Alert |
| 09/16/2022 | TDOC | Buy Now | Teladoc Health | $9.34 | — | — | Initiates | → Sector Weight | Get Alert |
| 09/16/2022 | VEEV | Buy Now | Veeva Sys | $185.74 | 18.45% | → $220 | Initiates | → Overweight | Get Alert |
| 02/08/2022 | ALIT | Buy Now | Alight | $7.35 | 104.08% | → $15 | Initiates | → Overweight | Get Alert |
| 01/07/2022 | VEEV | Buy Now | Veeva Sys | $185.74 | 48.06% | → $275 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/21/2021 | GDRX | Buy Now | GoodRx Holdings | $8.27 | 444.14% | → $45 | Initiates | → Overweight | Get Alert |
| 11/19/2021 | TDOC | Buy Now | Teladoc Health | $9.34 | 1345.4% | — | Maintains | Equal-Weight | Get Alert |
